Intimation about 40th Annual general Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has informed the BSE that its Board of Directors approved convening the 40th Annual General Meeting (AGM) on Tuesday, 30th September 2025 at 4:30 PM. The intimation has been filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The communication was signed by Company Secretary Pratika Mhambray and dated 13th August 2025. No agenda items, financial results, or material business decisions were disclosed in this filing.
This is a routine compliance filing and does not have any direct impact on shareholders or the stock price. Investors should watch for the AGM notice and any business resolutions put forward for shareholder approval closer to the meeting date.